1211P IMpower010: Ctdna Status and 5y DFS Follow Up in Patients (pts) with Resected NSCLC Who Received Adjuvant Chemotherapy (chemo) Followed by Atezolizumab (atezo) or Best Supportive Care (BSC)
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined